As of 2025-07-07, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (36.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -50817.0%.
The range of the Relative Valuation is (37.00) - (35.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 18.9x | 18.5x |
| Forward P/E multiples | 19.8x - 21.7x | 20.6x |
| Fair Price | (37.00) - (35.28) | (36.62) |
| Upside | -51348.1% - -48964.5% | -50817.0% |
| Date | P/E |